Anika Therapeutics Inc. 5Y Operating CF Growth (per Share)

5Y Operating CF Growth (per Share) of ANIK for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Operating CF Growth (per Share) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Operating CF Growth (per Share) for 2021 was -16.01% (a -8.67% decrease from previous year)
  • Annual 5Y Operating CF Growth (per Share) for 2020 was -17.53% (a 8665.0% increase from previous year)
  • Annual 5Y Operating CF Growth (per Share) for 2019 was -0.2% (a -103.21% decrease from previous year)
Visit stockrow.com/ANIK for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Operating CF Growth (per Share) of Anika Therapeutics Inc.

Most recent 5Y Operating CF Growth (per Share)of ANIK including historical data for past 10 years.

Interactive Chart of 5Y Operating CF Growth (per Share) of Anika Therapeutics Inc.

Anika Therapeutics Inc. 5Y Operating CF Growth (per Share) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 -16.01%
2020 -17.53%
2019 -0.2%
2018 6.24%
2017 28.62%
2016 19.06%
2015 21.25%
2014 0.2%
2013 -5.87%
2012 -22.25%
2011 -14.1%

Business Profile of Anika Therapeutics Inc.

Sector: Healthcare
Industry: Medical Devices